The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
BRUNNER, K. T., Mauël, J., Cerottini, J. C., & Chapuis, B. (1968) · PubMed Central · Cited by 1,367
Induction of Bystander T Cell Proliferation by Viruses and Type I Interferon in Vivo
Tough, D. F., Borrow, P., & Sprent, J. (1996) · Science · doi:10.1126/science.272.5270.1947 · Cited by 1,077
Mackett, M., Smith, G. L., & Moss, B. (1984) · Journal of Virology · doi:10.1128/jvi.49.3.857-864.1984 · Cited by 644
Self-citationMolecular analysis of the association of HLA-B53 and resistance to severe malaria
Hill, A. V. S., Elvin, J., Willis, A. C., Aidoo, M., Allsopp, C. E. M., Gotch, F. M., Ming Gao, X., Takiguchis, M., Greenwood, B. M., Townsend, A. R. M., et al. (1992) · Nature · doi:10.1038/360434a0 · Cited by 640
Self-citationNonreplicating vaccinia vector efficiently expresses recombinant genes.
Sutter, G., & Moss, B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.22.10847 · Cited by 600
Romero, P., Maryanski, J. L., Corradin, G., Nussenzweig, R. S., Nussenzweig, V., & Zavala, F. (1989) · Nature · doi:10.1038/341323a0 · Cited by 505
Symons, J. A., Alcamí, A., & Smith, G. L. (1995) · Cell · doi:10.1016/0092-8674(95)90076-4 · Cited by 490
Self-citationAlcami, A., & Smith, G. L. (1992) · Cell · doi:10.1016/0092-8674(92)90274-g · Cited by 482
Self-citationProtection against malaria by immunization with plasmid DNA encoding circumsporozoite protein.
Sedegah, M., Hedstrom, R., Hobart, P., & Hoffman, S. L. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.21.9866 · Cited by 447
Alcamí, A., & Smith, G. L. (1995) · Journal of Virology · doi:10.1128/jvi.69.8.4633-4639.1995 · Cited by 301
Self-citation
Cited by
DNA Vaccines: Immunology, Application, and Optimization
Gurunathan, S., Klinman, D. M., & Seder, R. A. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.927 · Cited by 1,207
Development of a preventive vaccine for Ebola virus infection in primates
Sullivan, N. J., Sanchez, A., Rollin, P. E., Yang, Z.-Y., & Nabel, G. J. (2000) · Nature · doi:10.1038/35046108 · Cited by 663
McShane, H., Pathan, A. A., Sander, C. R., Keating, S. M., Gilbert, S. C., Huygen, K., Fletcher, H. A., & Hill, A. V. S. (2004) · Nature Medicine · doi:10.1038/nm1128 · Cited by 570
Self-citationMcConkey, S. J., Reece, W. H. H., Moorthy, V. S., Webster, D., Dunachie, S., Butcher, G., Vuola, J. M., Blanchard, T. J., Gothard, P., Watkins, K., et al. (2003) · Nature Medicine · doi:10.1038/nm881 · Cited by 553
Self-citationGreenwood, B. M., Bojang, K., Whitty, C. J., & Targett, G. A. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66420-3 · Cited by 497
DNA vaccines: an historical perspective and view to the future
Liu, M. A. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00980.x · Cited by 468
Immunotherapy of cancer in 2012
Kirkwood, J. M., Butterfield, L. H., Tarhini, A. A., Zarour, H., Kalinski, P., & Ferrone, S. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20132 · Cited by 436
Delany, I., Rappuoli, R., & De Gregorio, E. (2014) · EMBO Molecular Medicine · doi:10.1002/emmm.201403876 · Cited by 420
DNA vaccines: precision tools for activating effective immunity against cancer
Rice, J., Ottensmeier, C. H., & Stevenson, F. K. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2326 · Cited by 415
DNA and RNA-based vaccines: principles, progress and prospects
Leitner, W. W., Ying, H., & Restifo, N. P. (1999) · Vaccine · doi:10.1016/s0264-410x(99)00271-6 · Cited by 402
Vaccines against intracellular infections requiring cellular immunity
Seder, R. A., & Hill, A. V. S. (2000) · Nature · doi:10.1038/35021239 · Cited by 394
Self-citationThe prime-boost strategy: exciting prospects for improved vaccination
Ramshaw, I. A., & Ramsay, A. J. (2000) · Immunology Today · doi:10.1016/s0167-5699(00)01612-1 · Cited by 369
Recombinant vaccines and the development of new vaccine strategies
Nascimento, I. P., & Leite, L. C. C. (2012) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2012007500142 · Cited by 367
Goonetilleke, N. P., McShane, H., Hannan, C. M., Anderson, R. J., Brookes, R. H., & Hill, A. V. S. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.3.1602 · Cited by 360
Self-citationViruses as vaccine vectors for infectious diseases and cancer
Draper, S. J., & Heeney, J. L. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2240 · Cited by 353
Jump-starting the immune system: prime–boosting comes of age
Woodland, D. L. (2004) · Trends in Immunology · doi:10.1016/j.it.2003.11.009 · Cited by 346
Liu, M. A. (2003) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2003.01140.x · Cited by 344
Recent developments in adjuvants for vaccines against infectious diseases
O'Hagan, D. T., MacKichan, M. L., & Singh, M. (2001) · Biomolecular Engineering · doi:10.1016/s1389-0344(01)00101-0 · Cited by 332
Kent, S. J., Zhao, A., Best, S. J., Chandler, J. D., Boyle, D. B., & Ramshaw, I. A. (1998) · Journal of Virology · doi:10.1128/jvi.72.12.10180-10188.1998 · Cited by 325
Modified Vaccinia Virus Ankara
Volz, A., & Sutter, G. (2017) · Advances in Virus Research · doi:10.1016/bs.aivir.2016.07.001 · Cited by 323
Hanke, T., Samuel, R. V., Blanchard, T. J., Neumann, V. C., Allen, T. M., Boyson, J. E., Sharpe, S. A., Cook, N., Smith, G. L., Watkins, D. I., et al. (1999) · Journal of Virology · doi:10.1128/jvi.73.9.7524-7532.1999 · Cited by 304
Self-citationProgress and challenges for malaria vaccines
Richie, T. L., & Saul, A. (2002) · Nature · doi:10.1038/415694a · Cited by 303
Kamath, A. T., Feng, C. G., Macdonald, M., Briscoe, H., & Britton, W. J. (1999) · Infection and Immunity · doi:10.1128/.67.4.1702-1707.1999 · Cited by 301
Ada, G. (2001) · New England Journal of Medicine · doi:10.1056/nejmra011223 · Cited by 291
Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation
Ewer, K. J., O’Hara, G. A., Duncan, C. J. A., Collins, K. A., Sheehy, S. H., Reyes-Sandoval, A., Goodman, A. L., Edwards, N. J., Elias, S. C., Halstead, F. D., et al. (2013) · Nature Communications · doi:10.1038/ncomms3836 · Cited by 286
Self-citationAnnulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis
Kaufmann, S. H. E., & McMichael, A. J. (2005) · Nature Medicine · doi:10.1038/nm1221 · Cited by 273
Current status of malaria and potential for control
Phillips, R. S. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.1.208-226.2001 · Cited by 266
Forrest, B. D., Pride, M. W., Dunning, A. J., Capeding, M. R. Z., Chotpitayasunondh, T., Tam, J. S., Rappaport, R., Eldridge, J. H., & Gruber, W. C. (2008) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00397-07 · Cited by 256
Microparticles as vaccine adjuvants and delivery systems
O’Hagan, D. T., & Singh, M. (2003) · Expert Review of Vaccines · doi:10.1586/14760584.2.2.269 · Cited by 214
DOCK8 is essential for T‐cell survival and the maintenance of CD8+ T‐cell memory
Lambe, T., Crawford, G., Johnson, A. L., Crockford, T. L., Bouriez‐Jones, T., Smyth, A. M., Pham, T. H. M., Zhang, Q., Freeman, A. F., Cyster, J. G., et al. (2011) · European Journal of Immunology · doi:10.1002/eji.201141759 · Cited by 115
Kinoshita, A., Whelan, C. M., Berezovska, O., & Hyman, B. T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203372200 · Cited by 109
Effector and memory CD8+ T cells as seen in immunity to malaria
Morrot, A., & Zavala, F. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00175.x · Cited by 55
Zhang, L., Ma, Q., Yang, W., Qi, X., Yao, Z., Liu, Y., Liang, L., Wang, X., Ma, C., Huang, L., et al. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.10.023 · Cited by 15
Metadata
- Authors
- Schneider, J., Gilbert, S. C., Blanchard, T. J., Hanke, T., Robson, K. J., Hannan, C. M., Becker, M., Sinden, R., Smith, G. L., & Hill, A. V. S.
- Venue
- Nature Medicine
- Published
- 1998-04-01
- Volume
- 4
- Issue
- 4
- Pages
- 397-402
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2062096354
- Cited by
- 644
- References
- 29
- FWCI
- 66.69
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.